flumazenil has been researched along with cyclic gmp in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchard, JC; Boireau, A; Dubédat, P; Farges, G; Laduron, PM; Martel, M | 1 |
| Bonetti, EP; Burkard, WP; Haefely, W | 1 |
| Moura, D; Soares-da-Silva, P | 1 |
| Romstedt, K | 1 |
| Burkard, WP; Haefely, W; Keller, HH; Möhler, H; Richards, JG | 1 |
| Koe, BK; Lebel, LA | 1 |
| Biggio, G; Concas, A; Salis, M; Serra, M | 1 |
| Hall, ED; Oostveen, JA; Sethy, VH; Wu, H | 1 |
| Ansaldo, MA; Fedele, E; Raiteri, M; Varnier, G | 1 |
1 review(s) available for flumazenil and cyclic gmp
| Article | Year |
|---|---|
[Drug activation of GABAergic transmission in the central nervous system: benzodiazepines and GABAergic agonists].
Topics: Animals; Benzodiazepines; Benzodiazepinones; Brain; Carbolines; Chemical Phenomena; Chemistry; Cyclic GMP; Diazepam; Flumazenil; gamma-Aminobutyric Acid; Humans; Receptors, GABA-A; Synaptic Transmission; Valproic Acid | 1985 |
8 other study(ies) available for flumazenil and cyclic gmp
| Article | Year |
|---|---|
In vivo determination of the profile of benzodiazepine ligands by comparing the inhibition of 3H-Ro 15-1788 binding to the modulation of cGMP levels in mouse cerebellum.
Topics: Animals; Cerebellum; Cyclic GMP; Diazepam; Dose-Response Relationship, Drug; Flumazenil; Ligands; Male; Mice; Naphthyridines; Piperazines; Receptors, GABA-A; Sulfur Compounds; Tritium | 1988 |
The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice.
Topics: Alkaloids; Animals; Benzodiazepines; Benzodiazepinones; Carbolines; Cerebellum; Cyclic GMP; Flumazenil; Harmaline; Indoles; Male; Mice; Mice, Inbred Strains; Motor Activity; Receptors, GABA-A | 1985 |
Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Benzodiazepinones; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Diazepam; Epinephrine; Flumazenil; Flurazepam; Humans; Malondialdehyde; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thrombin; Type C Phospholipases | 1985 |
Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Brain; Cerebellum; Cerebral Cortex; Cyclic GMP; Diazepam; Dopamine; Flumazenil; Flunitrazepam; Kinetics; Mice; Receptors, Drug; Receptors, GABA-A | 1981 |
Contrasting effects of ethyl beta-carboline-3-carboxylate (beta CCE) and diazepam on cerebellar cyclic GMP content and antagonism of both effects by Ro 15-1788, a specific benzodiazepine receptor blocker.
Topics: Animals; Benzodiazepinones; Carbolines; Cerebellum; Cyclic GMP; Diazepam; Flumazenil; In Vitro Techniques; Indoles; Isoniazid; Male; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A | 1983 |
Increase of cyclic GMP in cerebellum by methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM).
Topics: Animals; Benzodiazepinones; Carbolines; Cerebellar Cortex; Cyclic GMP; Diazepam; Dose-Response Relationship, Drug; Flumazenil; Indoles; Male; Muscimol; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A; Stimulation, Chemical | 1983 |
Neuroprotective effects of the GABA(A) receptor partial agonist U-101017 in 3-acetylpyridine-treated rats.
Topics: Adenosine Triphosphate; Animals; Body Temperature; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Flumazenil; GABA Modulators; GABA-A Receptor Agonists; Male; Movement; Neuroprotective Agents; Olivary Nucleus; Pyridines; Quinolines; Rats; Rats, Wistar; Time Factors | 1997 |
Benzodiazepine-sensitive GABA(A) receptors limit the activity of the NMDA/NO/cyclic GMP pathway: a microdialysis study in the cerebellum of freely moving rats.
Topics: Animals; Anti-Anxiety Agents; Bicuculline; Cerebellum; Cyclic GMP; Diazepam; Flumazenil; Infusions, Parenteral; Kinetics; Male; Microdialysis; Muscimol; N-Methylaspartate; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Zolpidem | 2000 |